TMDXTransMedics Group, Inc.

$4B

FY 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$13M+69.4% YoY

Gross Profit

$6M44.1% margin

Operating Income

-$20M-155.5% margin

Net Income

-$24M-182.5% margin

EPS (Diluted)

$-1.23

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$26M

Stock-Based Comp.

$144,000

Balance Sheet

Total Assets

$42M

Total Liabilities

$47M

Stockholders' Equity

-$5M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$8M	+69.4%
Gross Profit	$6M	$2M	+168.3%
Operating Income	-$20M	-$20M	+0.9%
Net Income	-$24M	-$21M	-14.1%

TMDX FY 2018 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena